GLP-1 Weight Loss in Lansing, MI: What It Costs When No One Will Tell You the Price
Lansing's obesity rate against Michigan's, an unresolved Medicaid picture, a fully consult-gated local cash market, and two facility HPSAs inside the city.
39.9% of Lansing adults have obesity (CDC PLACES 2025 release, BRFSS 2023) 1, 4.5 points above Michigan's statewide rate of 35.4% (CDC BRFSS 2023) 2. Lansing runs meaningfully heavier than the state it anchors.
It is a city of 113,884 inside a 479,722-person metro, with a median household income of $55,366 and 7.4% uninsured 3456. Nobody in the city will quote a GLP-1 price before a visit.
County
Ingham County (the city also extends into small parts of Eaton and Clinton counties)
Ingham/Eaton counties carry an active HRSA Primary Care HPSA for the low-income population ("LI-Greater Lansing SA", ID 1262071134; designated; score 14; population-to-provider ratio 5,535:1; designation population 107,273), spanning both counties' rural and non-rural tracts. Two facility-based Primary Care HPSAs sit inside Lansing itself: the County of Ingham Health Department FQHC (ID 126999264Y, score 17, service population 58,661) and Care Free Medical Inc., an FQHC Look-Alike free clinic (ID 1262293456, score 14, service population 150,108). The shortage is concentrated in the low-income population specifically, not city-wide — real and current as of the HRSA source file's Aug 27, 2026 update.8
Specialist access
University of Michigan Health-Sparrow runs a hospital-based "Lansing Bariatrics & Weight Management" program (bariatric surgery, insurance-billed); its public page does not mention GLP-1 medications and publishes no self-pay price. HRSA does not designate shortage areas for endocrinology or obesity medicine specifically — only primary care, dental, and mental health are tracked — so no federal shortage ratio exists for that specialty; this is reported as a data gap, not a guess. The one verified independent med spa physically in the city, Aesthetics Medical Spa, offers semaglutide/tirzepatide but gates all pricing behind a required consultation, leaving telehealth as the only route in Lansing to a transparent, published price.8
Medicaid coverage note
Michigan Medicaid's coverage of GLP-1 medications specifically for weight loss could not be confirmed. KFF's 50-State Medicaid Budget Survey FY 2025-2026 — which tracks state GLP-1/anti-obesity Medicaid coverage nationally as of October 1, 2025 — lists 16 states that cover GLP-1s for obesity treatment, and Michigan is not one of them; that is the clearest verified signal available, and it points toward weight-loss GLP-1s not being a standard Michigan Medicaid benefit today (coverage for type 2 diabetes and other non-obesity indications is a separate matter and more commonly covered). A separately-circulated claim of a January 1, 2026 Michigan budget rollback, with a specific dollar figure and enrollee counts, could not be verified at any primary source — Michigan's own bulletin pages were unreachable and neither Bridge Michigan nor the Michigan League for Public Policy show matching reporting — so that claim is being treated as unconfirmed, not fact, pending a primary MDHHS bulletin or dated news article.9
What Michigan Medicaid does about weight-loss GLP-1s, honestly
Michigan Medicaid's coverage of GLP-1 medications specifically for weight loss could not be confirmed. KFF's 50-State Medicaid Budget Survey FY 2025-2026, which tracks state GLP-1 and anti-obesity Medicaid coverage as of October 1, 2025, lists 16 states that cover GLP-1s for obesity treatment, and Michigan is not one of them 9. That is the clearest verified signal available, and it points toward weight-loss GLP-1s not being a standard Michigan Medicaid benefit today. Coverage for type 2 diabetes and other non-obesity indications is a separate matter and more commonly covered.
A separately circulated claim of a January 1, 2026 Michigan budget rollback, with a specific dollar figure and enrollee counts, could not be verified at any primary source. Michigan's own bulletin pages were unreachable and neither Bridge Michigan nor the Michigan League for Public Policy show matching reporting, so that claim is treated as unconfirmed, not fact, pending a primary MDHHS bulletin or dated article. Anyone on Michigan Medicaid should confirm current coverage with MDHHS or their managed-care plan.
What GLP-1 care costs in Lansing today
Aesthetics Medical Spa, at 1568 Lake Lansing Road, runs a dedicated semaglutide and tirzepatide page (which misspells tirzepatide as "Trizepatide") and, confirmed by direct fetch on 2026-08-28, carries no dollar figure anywhere on it. Its own words: "Several factors will determine the cost of Semaglutide and Trizepatide treatments in Lansing. The best way to find out how much this treatment will cost you is to meet with Dr. Ronan for a consultation." 10
University of Michigan Health-Sparrow's Lansing Bariatrics & Weight Management program is the other local option, and it is a bariatric-surgery service framed entirely around insurance, "typically covered by most insurances," with a payer list. No GLP-1 medication and no self-pay or cash price appears anywhere on the page. Checked 2026-08-28 11.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide, both on 12-month plans. It is published up front, with nothing to negotiate at a consultation.
A low-income shortage designation spanning two counties
Ingham and Eaton counties carry an active HRSA Primary Care HPSA for the low-income population, "LI-Greater Lansing SA" (ID 1262071134, score 14, population-to-provider ratio 5,535:1, designation population 107,273), spanning both counties' rural and non-rural tracts. Two facility-based Primary Care HPSAs sit inside Lansing itself: the County of Ingham Health Department FQHC (ID 126999264Y, score 17, service population 58,661) and Care Free Medical Inc., an FQHC Look-Alike free clinic (ID 1262293456, score 14, service population 150,108). The shortage is concentrated in the low-income population specifically, not city-wide, and is current as of the HRSA file's Aug 27, 2026 update 8.
HRSA does not designate shortage areas for endocrinology or obesity medicine, only primary care, dental, and mental health, so no federal shortage ratio exists for that specialty here. That is a data gap, not a finding of adequate access 8.
With the hospital program priced through insurance and the one independent med spa gating cost behind a consultation, telehealth is the only route in Lansing to a transparent, published price. See the Michigan GLP-1 overview for statewide context.
Astra treats patients in Michigan through state-licensed physicians.
Local options
Aesthetics Medical Spa — 1568 Lake Lansing Road, Lansing, MI 48912 — In-city med spa with a dedicated semaglutide/tirzepatide page (the page itself misspells "Tirzepatide" as "Trizepatide"). Confirmed by direct fetch on 2026-08-28: no dollar figure appears anywhere on the page. Exact quote: "Several factors will determine the cost of Semaglutide and Trizepatide treatments in Lansing. The best way to find out how much this treatment will cost you is to meet with Dr. Ronan for a consultation." https://www.aestheticslansing.com/body/semaglutide(checked 2026-08-28)
University of Michigan Health-Sparrow — Lansing Bariatrics & Weight Management (hospital-based) — Hospital-affiliated bariatric surgery program serving Lansing. Page frames cost entirely around insurance ("typically covered by most insurances," with a payer list); no GLP-1 medications and no self-pay/cash price appear anywhere on the page. https://www.uofmhealthsparrow.org/bariatricsurgery(checked 2026-08-28)
Frequently asked questions
How much does semaglutide or tirzepatide cost in Lansing, MI?
No provider physically inside Lansing publishes a self-pay GLP-1 price online — the in-city med spa Aesthetics Medical Spa states cost is set only "at a consultation," and the hospital-based UM Health-Sparrow program is priced entirely through insurance. Astra's cash price is published and flat nationwide, including Lansing: $68/mo for semaglutide and $118/mo for tirzepatide, both on 12-month plans ($816 and $1,416 billed annually).
Why won't local Lansing weight-loss clinics post their GLP-1 prices online?
It's standard practice in the med-spa and bariatric-surgery world to price case-by-case after a consultation, since dose, visit cadence, and add-ons vary. Aesthetics Medical Spa's own site is explicit about this: cost is determined "at a consultation with Dr. Ronan," not published in advance. That leaves Lansing residents with no way to comparison-shop online before booking an appointment.
Does Michigan Medicaid cover Wegovy or Zepbound for weight loss?
It's unclear, and we're not going to guess. KFF's national 50-State Medicaid Budget Survey (GLP-1 coverage as of Oct 1, 2025) lists 16 states that cover GLP-1s for obesity — Michigan isn't one of them, which suggests weight-loss GLP-1s aren't a standard Michigan Medicaid benefit today. Diabetes and other non-obesity indications are handled separately and are more commonly covered. Anyone on Michigan Medicaid should confirm current coverage directly with MDHHS or their managed-care plan.
What is Lansing's obesity rate compared to the rest of Michigan?
39.9% of Lansing adults have obesity (CDC PLACES, BRFSS 2023 release), about 4.5 percentage points above Michigan's statewide rate of 35.4% (CDC BRFSS 2023) — Lansing runs meaningfully heavier than the state it anchors.
Is Astra cheaper in Lansing?
There's no local Lansing price to compare against — every in-city GLP-1 option we checked withholds pricing until after a consultation, so a head-to-head number doesn't exist. What we can say plainly: Astra's price is the same $68/mo (semaglutide) and $118/mo (tirzepatide) in Lansing as it is everywhere else Astra operates, published up front on a 12-month plan, with nothing to negotiate at a consultation.